Carbonite to Present at Upcoming Investor Conferences

13Feb

Carbonite to Present at Upcoming Investor Conferences

Portfolio News
Carbonite, Inc., a global leader in data protection, today announced that the company is scheduled to participate at the following investor events:
  • JMP Securities Technology Conference on Tuesday, February 26th, 2019 at 9:00 a.m. pacific time
  • Morgan Stanley Technology, Media and Telecom Conference on Wednesday, February 27th, 2019 at 4:25 p.m. pacific time
Read more >>

Share this post

Related Posts

20Jun

eSight and Varioptic announce the availability of eSight 3 electronic glasses

Varioptic is happy to announce that its advanced Caspian module is a part of the recently launched eSight 3, a... read more
26Oct

Fujifilm Selects Aras as PLM Platform for Product Realization Process

Aras ®, the next leader in enterprise Product Lifecycle Management (PLM) software, today announced that Fujifilm’s Medical Systems Business Division,... read more
28May

Xylyx Bio releases advanced disease model system to improve cancer drug discovery

Xylyx Bio, a leader in predictive disease models, today announced the release of its IN SITE™ Metastasis Kit, a highly... read more
26May

Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2021 Virtual Congress

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced the... read more
04Sep

Board adds $1M to help get more Utah students connected to internet

The board also approved setting aside $452,000 from the Utah K-12 CARES set aside funds to obtain a K-12 license... read more
16Jun

US franchise Smoothie King launches Premama prenatal smoothie

US-based franchise company Smoothie King has partnered with prenatal vitamins company Premama to launch a new smoothie. Read more >> read more
15Sep

Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2018 ACR Annual Meeting

Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to... read more
07Mar

Budgetary Strategies for Recycling and Waste Reduction in the Circular Economy

Talking about our expectations for Union Budget 2024, it’s true that the government should be more inclined towards offering tax... read more
30Sep

Enrich Therapeutics develops desktop cell isolation system for therapeutic discovery

Enrich Therapeutics is developing a desktop static cell isolation technology that can separate clones to accelerate therapeutic discovery. We spoke... read more
16Dec

In a World First, a Patient’s Antibody Cells Were Just Genetically Engineered

Our B cells help prevent us from getting sick. Their job is to make antibodies, immune system proteins that fight... read more